{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:28:08Z","timestamp":1787243288801,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1KL2TR004421-01"],"award-info":[{"award-number":["1KL2TR004421-01"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008169","name":"Minneapolis Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1053\/j.seminhematol.2024.11.006","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T02:28:23Z","timestamp":1732933703000},"page":"11-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["FaMMily Affairs: Dissecting inherited contributions to multiple myeloma risk"],"prefix":"10.1053","volume":"62","author":[{"given":"Saoirse","family":"Bodnar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehilla","family":"Brander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Iverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lagana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Onel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundar","family":"Jagannath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-5136","authenticated-orcid":false,"given":"Santiago","family":"Thibaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2024.11.006_bib0001","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.006_bib0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13045-023-01521-6","article-title":"The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans","volume":"17","author":"Liu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0004","series-title":"Veterans and agent orange: update 2008","year":"2009"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0005","first-page":"4179","article-title":"Occupational exposure and multiple myeloma risk: an updated review of meta-analyses","volume":"10","author":"Georgakopoulou","year":"2021","journal-title":"J. Clin. Med. Res."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41408-022-00709-2","article-title":"Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster","volume":"12","author":"Zeig-Owens","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0007","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/bloodadvances.2023010815","article-title":"Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups","volume":"8","author":"Shah","year":"2024","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0008","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1182\/bloodadvances.2023010822","article-title":"It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma","volume":"7","author":"Choa","year":"2023","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0009","unstructured":"Myeloma - cancer stat facts. SEER https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html Accessed Date October 15, 2024."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0011","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0012","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0013","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41408-018-0132-1","article-title":"Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry","volume":"8","author":"Baughn","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0014","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ajh.21325","article-title":"Familial myeloma and monoclonal gammopathy: a report of eight African American families","volume":"84","author":"Jain","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa0708704","article-title":"Familial myeloma","volume":"359","author":"Lynch","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0016","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2385::AID-CNCR13>3.0.CO;2-A","article-title":"Multiple myeloma and family history of cancer among blacks and whites in the U.S","volume":"85","author":"Brown","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0017","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10552-015-0685-2","article-title":"Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features","volume":"27","author":"VanValkenburg","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00051914","article-title":"Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study","volume":"3","author":"Eriksson","year":"1992","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0019","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/1097-0142(19851015)56:8<2133::AID-CNCR2820560842>3.0.CO;2-F","article-title":"Multiple myeloma and family history of cancer. A case-control study","volume":"56","author":"Bourguet","year":"1985","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1532-5415.1989.tb05495.x","article-title":"Familial aggregation of multiple myeloma and central nervous system diseases","volume":"37","author":"Grufferman","year":"1989","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0021","doi-asserted-by":"crossref","unstructured":"Liner, M.S., Mclaughlin, J.K., Harlow, S.D. & Fraumeni, J.F. Family history of autoimmune disorders and cancer in multiple myeloma. Int. J. Transportation Privatization & Public Policy 17, 512\u2013513.","DOI":"10.1093\/ije\/17.3.512"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0022","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1158\/1055-9965.EPI-06-0097","article-title":"Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women","volume":"15","author":"Landgren","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0023","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.24514","article-title":"Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden","volume":"125","author":"Kristinsson","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0024","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","article-title":"Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands","volume":"86","author":"Goldgar","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ejh.13757","article-title":"Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study","volume":"108","author":"Langseth","year":"2022","journal-title":"Eur. J. Haematol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0026","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","article-title":"Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden","volume":"114","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0027","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2008-12-192575","article-title":"Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance","volume":"114","author":"Vachon","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0028","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.ejca.2005.11.033","article-title":"Familial risks and temporal incidence trends of multiple myeloma","volume":"42","author":"Altieri","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0029","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood.2019001362","article-title":"Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk","volume":"134","author":"Sud","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/leu.2015.279","article-title":"Search for familial clustering of multiple myeloma with any cancer","volume":"30","author":"Frank","year":"2016","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjh.14199","article-title":"Multiple myeloma and family history of lymphohaematopoietic cancers: results from the International Multiple Myeloma Consortium","volume":"175","author":"Schinasi","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0032","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10689-016-9907-3","article-title":"Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families","volume":"15","author":"Read","year":"2016","journal-title":"Fam. Cancer"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0033","doi-asserted-by":"crossref","first-page":"42601","DOI":"10.1038\/srep42601","article-title":"Risk of other cancers in families with melanoma: novel familial links","volume":"7","author":"Frank","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0034","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.eururo.2016.07.031","article-title":"Familial associations between prostate cancer and other cancers","volume":"71","author":"Frank","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0035","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.ejca.2004.07.016","article-title":"Familial association of colorectal adenocarcinoma with cancers at other sites","volume":"40","author":"Hemminki","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0036","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1897-4287-5-2-72","article-title":"Familial multiple myeloma: report on two families and discussion of screening options","volume":"5","author":"Gerkes","year":"2007","journal-title":"Hered. Cancer Clin. Pract."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0037","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.1999.01415.x","article-title":"Familial multiple myeloma: report of fifteen families","volume":"105","author":"Grosbois","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0038","first-page":"58","article-title":"Familial occurrence of multiple myeloma and monoclonal gammopathy of undetermined significance in 5 siblings","volume":"75","author":"Bizzaro","year":"1990","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0039","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ajh.26785","article-title":"Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: a multicenter Intergroupe Francophone du My\u00e9lome study","volume":"98","author":"Dumontet","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0040","first-page":"170","article-title":"La maladie de kahler (myelomes multiples) chez deux soeurs","volume":"3","author":"Mandema","year":"1954","journal-title":"J. Genet. Hum."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0041","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/jnci\/93.19.1479","article-title":"Familial multiple myeloma: a family study and review of the literature","volume":"93","author":"Lynch","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0042","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1200\/JCO.2005.10.126","article-title":"Phenotypic heterogeneity in multiple myeloma families","volume":"23","author":"Lynch","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0043","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1038\/s41467-024-50932-7","article-title":"Deciphering the genetics and mechanisms of predisposition to multiple myeloma","volume":"15","author":"Went","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0044","doi-asserted-by":"crossref","first-page":"12050","DOI":"10.1038\/ncomms12050","article-title":"Genome-wide association study identifies multiple susceptibility loci for multiple myeloma","volume":"7","author":"Mitchell","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0045","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1038\/s41467-018-04989-w","article-title":"Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma","volume":"9","author":"Went","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0046","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/ncomms8213","article-title":"Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma","volume":"6","author":"Swaminathan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0047","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ng.993","article-title":"Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk","volume":"44","author":"Broderick","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0048","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ng.2733","article-title":"Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk","volume":"45","author":"Chubb","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0049","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41408-021-00468-6","article-title":"Germline variants at SOHLH2 influence multiple myeloma risk","volume":"11","author":"Duran-Lozano","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/bloodadvances.2019000491","article-title":"A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry","volume":"4","author":"Du","year":"2020","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0051","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41588-020-0580-y","article-title":"The GWAS Diversity Monitor tracks diversity by disease in real time","volume":"52","author":"Mills","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0052","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41431-021-00986-8","article-title":"A polygenic risk score for multiple myeloma risk prediction","volume":"30","author":"Canzian","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0053","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/bloodadvances.2016003111","article-title":"Direct evidence for a polygenic etiology in familial multiple myeloma","volume":"1","author":"Halvarsson","year":"2017","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007111","article-title":"Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk","volume":"14","author":"Waller","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0055","article-title":"Coffin-Siris syndrome and cancer susceptibility","volume":"1","author":"Borja","year":"2023","journal-title":"Genet Med Open"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0056","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ccell.2024.05.026","article-title":"IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma","volume":"42","author":"Bolomsky","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0057","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","article-title":"Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants","volume":"8","author":"Momozawa","year":"2022","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.11.006_bib0058","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/2643-3230.BCD-23-0208","article-title":"Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes","volume":"5","author":"Thibaud","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0059","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41588-024-01853-0","article-title":"Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes","volume":"56","author":"Skerget","year":"2024","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/leu.2013.199","article-title":"Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms","volume":"28","author":"Walker","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0061","first-page":"351","article-title":"Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies","volume":"109","author":"Stubbins","year":"2024","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0062","first-page":"461","article-title":"Re: Familial Multiple Myeloma: a Family study and review of the literature","volume":"94","author":"Sobol","year":"2002","journal-title":"CancerSpectrum Knowledge Environment"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.11.006_bib0063","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/bjh.19271","article-title":"Germline genetic variants in Turkish familial multiple myeloma\/monoclonal gammopathy of undetermined significance cases","volume":"204","author":"Akkus","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0064","first-page":"1338","article-title":"Thymic lymphomas in mice with a truncating mutation in Brca2","volume":"58","author":"Friedman","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0065","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood.V95.5.1869.005k09_1869_1871","article-title":"Germline CDKN2A mutation implicated in predisposition to multiple myeloma","volume":"95","author":"Dilworth","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0066","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1182\/blood.V90.10.4092","article-title":"The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4","volume":"90","author":"Mock","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0067","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/s41375-019-0452-6","article-title":"Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma","volume":"33","author":"Pertesi","year":"2019","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0068","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/0008-5472.CAN-17-1900","article-title":"Germline lysine-specific demethylase 1 (LSD1\/KDM1A) mutations confer susceptibility to multiple myeloma","volume":"78","author":"Wei","year":"2018","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0069","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1002\/cncr.30777","article-title":"Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles","volume":"123","author":"Bolli","year":"2017","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41408-021-00422-6","article-title":"Characterization of rare germline variants in familial multiple myeloma","volume":"11","author":"Catalano","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0071","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(09)70234-7","article-title":"Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study","volume":"10","author":"Grass","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0072","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(09)70294-3","article-title":"multiple myeloma, and paratarg-7","volume":"10","author":"Lynch","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0073","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-16-1045","article-title":"Interaction landscape of inherited polymorphisms with somatic events in cancer","volume":"7","author":"Carter","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0074","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fgene.2019.00424","article-title":"Germline risk contribution to genomic instability in multiple myeloma","volume":"10","author":"Janz","year":"2019","journal-title":"Front. Genet."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ng.2583","article-title":"The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma","volume":"45","author":"Weinhold","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0076","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood-2023-190878","article-title":"Confirmed Pathogenic Germline Variants in Cancer Predisposition Genes Incidentally Detected in Somatic Genomic Profiling of Multiple Myeloma Patients","volume":"142","author":"Thibaud","year":"2023","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.11.006_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109434","article-title":"The mechanism of SP1\/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription","volume":"119","author":"Jin","year":"2019","journal-title":"Biomed. Pharmacother."}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324001318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324001318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T10:07:58Z","timestamp":1741946878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324001318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0037196324001318"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.11.006","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FaMMily Affairs: Dissecting inherited contributions to multiple myeloma risk","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}